Management Guidelines in Patients on Antithrombotic Therapy Subjected to Surgical Intervention

• Authors: Małgorzata Buksińska-Lisik , Tomasz Pasierski
• Languages of publication: EN

Abstracts

EN

• Publisher: Index Copernicus International
• Journal: Polish Journal of Surgery
• Year: 2009
• Volume: 81
• Issue: 5
• Pages: 256-264

Dates

published

1 - 5 - 2009

online

8 - 9 - 2009

Contributors

author

Małgorzata Buksińska-Lisik

• Department of Cardiology and Vasular Diseases, Międzyleski Specialistic Hospital, Warsaw

author

Tomasz Pasierski

• Department of Cardiology and Vasular Diseases, Międzyleski Specialistic Hospital, Warsaw

References

• Pasierski T, Undas A, Zawilska K i wsp.: Leczenie przeciwzakrzepowe. Medycyna Praktyczna, Kraków 2007.
• Douketis J, Berger PB, Dunn AS, et al.: The Perioperative Management of Antithrombotic Therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest 2008; 133(Supl): 299S-339S.
• Theroux P, Waters D, Lam J, et al.: Reactivation of unstable angina after the discontinuation of heparin. N Engl J Med 1992; 327: 141-45.
• Bijsterveld NR, Peters RJG, Murphy SA, et al.: Recurrent cardiac ischemic events early after discontinuation of short term heparin treatment in acute coronary syndromes. J Am Coll Cardiol 2003; 42: 2083-89.[PubMed][Crossref]
• Bijsterveld NR, Moons AH, Meijers JCM, et al.: Rebound thrombin generation after heparin therapy in unstable angina: a randomized comparison between unfractonated and low molecular weight heparin. J Am Coll Cardiol 2002; 39: 811-17.[PubMed][Crossref]
• Genewein U, Haeberli A, Straub PW, et al.: Rebound after cessation of oral anticoagulant therapy: the biochemical evidence. Br J Haematol 1996; 92: 479-85.
• Hackam DG, Kopp A, Redelmeier DA: Prognostic implications of warfarin cessation after major trauma A population based cohort analysis. Circulation 2005; 111: 2250-56.
• Beving H, Zhao C, Albage A, et al.: Abnormally high platelet activity after discontinuation of acetylsalicylic acid treatment. Blood Coagul Fibrinolysis 1996; 7: 80-84.
• Vial JH, McLeod LJ, Roberts MS: Rebound elevation in urinary thromboxane B2 and 6-keto-PFF1 alpha exacerbation after aspirin withdrawal. Adv Prostaglandin Thromboxane Leukot Res 1991; 21A: 157-60.
• Biondi-Zoccai GGL, Lotrionte M, Agostoni P, et al.: A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50 279 patients at risk for coronary artery disease Eur Heart J 2006; 27: 2667-74.
• Berger JS, Roncaglioni MC, Avanzini F, et al.: Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials. JAMA 2006; 295: 306-13.
• Joner M, Finn AV, Farb A, et al.: Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 2006; 48: 193-202.[PubMed][Crossref]
• Ho PM, Peterson ED, Wang L, et al.: Incidence of death and acute myocardial infarction associated with stopping clopidogrel after acute coronary syndrome. JAMA 2008; 299: 532-39.
• Spertus JA, Kettelkamp R, Vance C, et al.: Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry. Circulation 2006; 113: 2803-09.
• Artang R, Dieter RS: Analysis of 36 reported cases of late thrombosis in drug-eluting stents placed in coronary arteries. Am J Cardiol 2007; 99: 1039-43.[WoS]
• Grines CL, Bonow RO, Casey DE, et al.: Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. Circulation 2007; 115: 813-18.[WoS]
• Burger W, Chemnitius JM, Kneissl GD, et al.: Low-dose aspirin for secondary cardiovascular prevention - cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation - review and meta-analysis. J Intern Med 2005; 257: 399-14.
• Nuttall GA, Santrach PJ, Oliver WC, et al.: The predictors of red cell transfusions in total hip arthroplasties. Transfusion 1996; 36: 144-49.
• Nuttall GA, Horlocker TT, Santrach PJ, et al.: Predictors of blood transfusions in spinal instrumentation and fusion surgery. Spine 2000; 25: 596-601.[Crossref][PubMed]
• Manning BJ, O'Brien N, Aravindan S, et al.: The effect of aspirin on blood loss and transfusion requirements in patients with femoral neck fractures. Injury 2004; 35: 121-24.[Crossref][PubMed]
• Hui CK, Lai KC, Yuen MF, et al.: Does withholding aspirin for one week reduce the risk of post-sphincterotomy bleeding? Aliment Pharmacol Ther 2002; 16: 929-36.
• Sorbi D, Norton I, Conio M, et al.: Postpolypectomy lower GI bleeding: descriptive analysis. Gastrointest Endosc 2000; 51: 690-06.[PubMed][Crossref]
• Eisen GM, Baron TH, Dominitz JA, et al.: Guideline on the management of anticoagulation and antiplatelet therapy for endoscopic procedures. Gastrointest Endosc 2002; 55: 775-79.
• Samama CM, Bastien O, Forestier F, et al.: Antiplatelet agents in the perioperative period: expert recommendations of the French Society of Anesthesiology and Intensive Care (SFAR) 2001 - summary statement. Can J Anaesth 2002; 49: S26-S35.
• Akopov SE, Suzuki S, Fredieu A, et al.: Withdrawal of warfarin prior to a surgical procedure: time to follow the guidelines? Cerebrovasc Dis 2005; 19: 337-42.[PubMed][Crossref]
• Kearon C, Hirsh J: Management of anticoagulation before and after elective surgery. N Engl J Med 1997; 336: 1506-11.
• Dunn A, Turpie AGG: Perioperative management of patients on oral anticoagulants: a systematic review. Arch Int Med 2003; 163: 901-08.
• Garcia DA, Regan S, Henault LE, et al.: Risk of thromboembolism with short-term interruption of warfarin therapy. Arch Intern Med 2008; 168: 63-69.[WoS]
• Wysokinski WE, McBane RD, Daniels PR: Periprocedural anticoagulation management of patients with nonvalvular atrial fibrillation. Mayo Clin Proc 2008; 83: 639-45.
• Wallace DL, Latimer MD, Belcher HJ: Stopping warfarin therapy is unnecessary for hand surgery. J Hand Surg 2004; 29: 203-05.
• White RH, McKittrick T, Hutchinson R, et al.: Temporary discontinuation of warfarin therapy: changes in the International Normalized ratio. Ann Intern Med 1995; 122: 40-42.
• Larson BJG, Zumberg MS, Kitchens CS: A feasibility study of continuing dose-reduced warfarin for invasive procedures in patients with high thromboembolic risk. Chest 2005; 127: 922-27.
• Bonow RO, Carabello BA, Chatterjee K, et al.: ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2006; 48(3): e1-148.
• Vahanian A, Baumgarter H, Bax J, et al.: Guidlines on the management of valvular heart disease. The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 2007; 28(2): 230-68.

Identifiers

DOI

10.2478/v10035-009-0040-y